Use of antidiabetic and lipid-lowering medications associated with lower scores of liver fibrosis biomarkers in non-alcoholic steatohepatitis (NASH) patients

JOURNAL OF HEPATOLOGY(2023)

引用 0|浏览2
暂无评分
关键词
liver fibrosis biomarkers,lipid-lowering scores,non-alcoholic
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要